Advertisement
Screener

Celularity Inc. (CELU) Form 425: Prospectus or communication for a business combination

1.5 / 5 stars · 16/54 Roast Me

Add as a preferred source on Google

Celularity Inc. Form 425: Prospectus or communication for a business combination

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-07-07: Form 425; Description FORM 425; Document ea143859-425_gxacquisition.htm.
  • 2021-07-01: Form 425; Description FORM 425; Document ea143674-425_gxacqco.htm.
  • 2021-06-29: Form 425; Description CURRENT REPORT; Document ea143515-8k_gxacquisit.htm.
  • 2021-06-22: Form 425; Description FILE TO DISCLOSE INFORMATION REGARDING BUSINESS COMBINATIONS; Document ea143031-425_gxacquisition.htm.
FiledFormPeriod of reportDescriptionDocument
2021-07-07425FORM 425ea143859-425_gxacquisition.htm
2021-07-01425FORM 425ea143674-425_gxacqco.htm
2021-06-29425CURRENT REPORTea143515-8k_gxacquisit.htm
2021-06-22425FILE TO DISCLOSE INFORMATION REGARDING BUSINESS COMBINATIONSea143031-425_gxacquisition.htm
2021-06-15425FORM 425ea142711-425_gxacquisition.htm
2021-05-14425CURRENT REPORTea140936-8k_gxacquisit.htm
2021-05-14425FORM 425ea140911-425_gxacquisition.htm
2021-05-10425CURRENT REPORTea140562-8k_gxacquisition.htm
2021-05-05425CURRENT REPORTea140393-8k_gxacquisition.htm
2021-04-30425CURRENT REPORTea140139-8k_gxacquisition.htm
2021-04-28425FORM 425ea139957-425_gxacquis.htm
2021-04-21425FORM 425ea139761-425_gxacquisition.htm
2021-04-20425FORM 425ea139684-425_gxacquis.htm
2021-04-13425FORM 425ea139405-425_gxacq.htm
2021-04-09425FORM 425ea139321-425_gxacquisition.htm
2021-03-18425CURRENT REPORTea137956-8k_gxacqcorp.htm
2021-02-11425FORM 425ea135212-425_gxacquis.htm
2021-02-02425425ea134472-425_gxacquis.htm
2021-02-01425FORM 425ea134370-425_gxacquisition.htm
2021-01-08425CURRENT REPORTea132952-8k_gxacquisit.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Edesa Biotech, Inc. (EDSA)Canada$0.039B
BriaCell Therapeutics Corp. (BCTX)$0.037B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Advertisement